On April 29, Jiang Sixian led an SJTU delegation to visit The University of Sydney (USYD) and signed an alliance agreement on biomedical engineering joint research with Michael Spence, President of USYD. According to the agreement, both parties will jointly fund a multidisciplinary translational medicine platform in the next five years, involving biomedical engineering, computing, and bioinformatics. 

This is the largest joint project between SJTU and an Australian university in recent years and is intended to carry out collaborative research projects of mutual interest, such as translational medicine, biomedical engineering, computer science, and bioinformatics. It is hoped that a new prospect for clinical medicine can be explored through the use of modern engineering technology to solve problems in clinical medicine, the establishment of a translational medicine research and development platform to achieve changes in medical engineering, and the adoption of international training to pursue knowledge dissemination in the integration of life sciences, natural sciences, and engineering. Spence believes that strategic, top-down planning at the university level will further enhance existing peer-to-peer collaborations between professors into a more sustainable and effective form. Shanghai Jiao Tong University is one of the few strategic partners of The University of Sydney in China.

After the signing ceremony, representatives from Ruijin Hospital affiliated to SJTU School of Medicine, School of Biomedical Engineering, School of Pharmacy, Shanghai Center for Systems Biomedicine and Infrastructure Division visited several institutions of The University of Sydney such as its old Faculty of Medicine and Health, Department of Computer Science and Field Robotics Laboratory, and especially the Charles Perkins Center to learn from its concept, planning, operation mode, and management system.